New hope for weight loss when popular drugs fail: stomach procedure studied

NCT ID NCT07190794

Recruiting now Disease control Sponsor: Boston Scientific Corporation Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 30 times

Summary

This study looks at 150 adults with obesity who stopped taking GLP-1 weight-loss drugs (like Wegovy or Mounjaro) because of side effects or not losing enough weight. It compares a procedure called endoscopic sleeve gastroplasty (ESG), which reduces stomach size, to lifestyle changes alone. The main goal is to see which approach leads to more weight loss after one year.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Bariendo
RECRUITING

Miami, Florida, 33179, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Brigham & Women's Hospital
NOT_YET_RECRUITING

Boston, Massachusetts, 02115, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
West Virginia University
NOT_YET_RECRUITING

Morgantown, West Virginia, 26506, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

OBESITY